Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 3;13(13):1144.
doi: 10.3390/cells13131144.

Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease

Yousef Tizabi  1 , Samia Bennani  2 , Nacer El Kouhen  2 , Bruk Getachew  1 , Michael Aschner  3
Affiliations
Review

Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease

Yousef Tizabi et al. Cells. .

Abstract

Huntington's disease (HD) is a rare but progressive and devastating neurodegenerative disease characterized by involuntary movements, cognitive decline, executive dysfunction, and neuropsychiatric conditions such as anxiety and depression. It follows an autosomal dominant inheritance pattern. Thus, a child who has a parent with the mutated huntingtin (mHTT) gene has a 50% chance of developing the disease. Since the HTT protein is involved in many critical cellular processes, including neurogenesis, brain development, energy metabolism, transcriptional regulation, synaptic activity, vesicle trafficking, cell signaling, and autophagy, its aberrant aggregates lead to the disruption of numerous cellular pathways and neurodegeneration. Essential heavy metals are vital at low concentrations; however, at higher concentrations, they can exacerbate HD by disrupting glial-neuronal communication and/or causing dysbiosis (disturbance in the gut microbiota, GM), both of which can lead to neuroinflammation and further neurodegeneration. Here, we discuss in detail the interactions of iron, manganese, and copper with glial-neuron communication and GM and indicate how this knowledge may pave the way for the development of a new generation of disease-modifying therapies in HD.

Keywords: Huntington’s disease; copper; glial cells; gut microbiota; gut–brain axis; heavy metals; iron; manganese; neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic diagram depicting how heavy metals, via their interactions with the neuroglia and gut microbiota, may contribute to Huntington’s disease (HD) pathology. A detailed understanding of this interaction can pave the way for novel therapeutic interventions in this rare but devastating neurological disease.
See this image and copyright information in PMC

Similar articles

  • Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    [No authors listed] [No authors listed] J Vis Exp. 2023 May 26;(195). doi: 10.3791/6561. J Vis Exp. 2023. PMID: 37235796
  • Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
    Salisbury L, Baraitser L. Salisbury L, et al. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
  • Peer Play.
    Scott HK, Cogburn M. Scott HK, et al. 2023 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30020595 Free Books & Documents.
  • Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.
    Liu H, McCollum A, Krishnaprakash A, Ouyang Y, Shi T, Ratovitski T, Jiang M, Duan W, Ross CA, Jin J. Liu H, et al. Int J Mol Sci. 2024 Nov 16;25(22):12315. doi: 10.3390/ijms252212315. Int J Mol Sci. 2024. PMID: 39596381 Free PMC article.
  • Von Willebrand Disease.
    Johnsen J. Johnsen J. 2009 Jun 4 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2009 Jun 4 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301765 Free Books & Documents. Review.
See all similar articles

References

    1. Ajitkumar A., De Jesus O. Huntington Disease. StatPearls Publishing; Treasure Island, FL, USA: 2024. - PubMed
    1. D’Egidio F., Castelli V., Lombardozzi G., Ammannito F., Cimini A., d’Angelo M. Therapeutic Advances in Neural Regeneration for Huntington’s Disease. Neural Regen. Res. 2024;19:1991–1997. doi: 10.4103/1673-5374.390969. - DOI - PMC - PubMed
    1. Heemskerk A.-W., Roos R.A.C. Aspiration Pneumonia and Death in Huntington’s Disease. PLoS Curr. 2012;4:RRN1293. doi: 10.1371/currents.RRN1293. - DOI - PMC - PubMed
    1. Finkbeiner S. Huntington’s Disease. Cold Spring Harb. Perspect. Biol. 2011;3:a007476. doi: 10.1101/cshperspect.a007476. - DOI - PMC - PubMed
    1. Rawlins M.D., Wexler N.S., Wexler A.R., Tabrizi S.J., Douglas I., Evans S.J.W., Smeeth L. The Prevalence of Huntington’s Disease. Neuroepidemiology. 2016;46:144–153. doi: 10.1159/000443738. - DOI - PubMed

Publication types